MRNX (Defiance Daily Target 2X Long MRNA ETF) Stock Analysis - Analyst Ratings

Defiance Daily Target 2X Long MRNA ETF (MRNX) is a publicly traded the market company. As of May 21, 2026, MRNX trades at $27.10 with a market cap of $0 and a P/E ratio of 0.00. MRNX moved -3.43% today. Year to date, MRNX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces MRNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate MRNX?

The average price target is $0.00.

MRNX Key Metrics

Key financial metrics for MRNX
MetricValue
Price$27.10
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume171.29K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

MRNX Analyst Consensus

MRNX analyst coverage data. Average price target: $0.00.

Latest MRNX News

Common questions about MRNX

What do analysts rate MRNX?
The average price target is $0.00.
Does Rallies show MRNX price targets?
Yes. Rallies tracks MRNX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is MRNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRNX. It does not provide personalized investment advice.
MRNX

MRNX